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Background: We aimed to investigate the potential causal associations of adiposity with 
asthma overall, asthma by atopic status or by levels of symptom control in a large adult 
population and stratified by sex. We also investigated the potential for reverse causation 
between asthma and risk of adiposity. 
Methods: We performed a bidirectional one-sample Mendelian randomization (MR) study 
using the Norwegian HUNT population including 56105 adults. 73 and 47 genetic variants 
were included as instrumental variables for body mass index (BMI) and waist-hip ratio 
(WHR), respectively. Asthma was defined as ever asthma, doctor diagnosed asthma and 
doctor diagnosed active asthma, and was further classified by atopic status or levels of 
symptom control. Causal odds ratio (OR) was calculated with the Wald method. 
Results: The ORs per 1 standard deviation (4.1 kg/m2) increase in genetically determined 
BMI were ranged from 1.36 to 1.49 for the three asthma definitions and similar for women 
and men. The corresponding ORs for non-atopic asthma (range 1.42 to 1.72) appeared 
stronger than those for the atopic asthma (range 1.18 to 1.26), but they were similar for 
controlled vs. partly controlled doctor diagnosed active asthma (1.43 vs. 1.44). There was no 
clear association between genetically predicted WHR and asthma risk or between genetically 
predicted asthma and the adiposity markers. 
Conclusions: Our MR study provided evidence of a causal association of BMI with asthma 
in adults, particularly with non-atopic asthma. There was no clear evidence of a causal link 






What is the key question? 
Is adiposity causally associated with the risk of asthma in adults, and does reverse causation 
exist? 
What is the bottom line? 
This study demonstrated evidence of a causal association of body mass index with asthma 
risk in adults, particularly with non-atopic asthma. There was no clear evidence of a causal 
link between waist-hip ratio (WHR) and asthma or of reverse causation between asthma and 
risk of adiposity. 
Why read on? 
This is the first study to assess a potential causal association between WHR and asthma in 






The relationship between adiposity and asthma has been extensively investigated in children 
and adults 1 2. A systematic review and meta-analysis of prospective observational studies has 
summarized that there is a similar association between adiposity, measured by body mass 
index (BMI), and asthma risk in women and men 1. Later, in a prospective cohort study using 
the Norwegian HUNT population we confirmed this association in both sexes 3. We also 
found an association between adiposity measured by waist circumference (WC) and asthma 
risk in women after adjustment for BMI 3. However, findings of the relationship between 
waist size independent of BMI and asthma risk have been inconsistent in observational 
studies 4 5. 
Observational studies have limitations to assess causal association due to confounding 
and reverse causation. The Mendelian randomization (MR) approach attempts to overcome 
these limitations with the use of genetic variants that serve as instrumental variables for the 
exposure of interest 6 7.  
Two MR studies in children found genetically determined increase in BMI being 
associated with a higher risk of asthma 8 9; the magnitude of the effect of BMI, however, 
differed by sex. The studies also identified a stronger effect on non-atopic than atopic asthma 
and an association between genetically determined fat mass or waist-hip ratio (WHR) and 
asthma risk 8 9. Two MR studies were performed in adults using the individual-level data 10 11; 
one study reported a 7% increase in risk for asthma associated with 1 kg/m2 increase in 
genetically predicted BMI 10, while the other reported a marginal association 11. None of the 
studies in adults has evaluated the potential effect modification by sex. Nor have they 
evaluated if waist-hip ratio, a marker for central adiposity, plays a causal role in asthma risk 
independently of BMI 10 11. Moreover, a possible causal association of adiposity with asthma 
symptom control has not been investigated in the previous MR studies. 
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Adults with asthma have a higher prevalence of obesity than their healthy peers 12. This 
may be explained by less physical activity among adults with asthma 13. An evaluation of the 
reverse causation, i.e. if asthma leads to increased adiposity, is thus warranted. In a large and 
homogenous population of adults, we aimed to investigate 1) if there was a causal association 
between adiposity and risk of asthma; 2) if there was effect modification by sex; 3) what was 
the magnitude of causal effect of adiposity on asthma by atopic status or by levels of asthma 
symptom control; and 4) if there was a potential reverse causation between asthma and the 
risk of adiposity. To achieve these aims, we performed a bidirectional one-sample MR study 
using the Norwegian HUNT population in which BMI and WHR were studied as markers of 






The study was based on data from the second survey of the HUNT Study (HUNT2, 1995-97). 
HUNT2 included 65227 subjects 20 years or older living in Nord-Trøndelag in Norway 
(participation rate 70%) 14. All participants completed two general questionnaires regarding 
health, lifestyle and socio-economic status, and attended a clinical examination.  
BMI, WHR and associated genetic variants 
Body weight, height, and waist and hip circumferences were measured by trained nurses as 
described elsewhere 14. Genotyping was performed using Illumina HumanCoreExome arrays 
15. Seventy-seven single nucleotide polymorphisms (SNPs) were selected as instrumental 
variables for BMI based on a large genome-wide association study (GWAS) from the GIANT 
consortium 16; these SNPs were associated with BMI in adults of European ancestry at a 
genome-wide significance (p <5x10-8), and the same SNPs were suggested for women and 
men. Data of two SNPs (rs12016871 and rs2033732) were not available in the HUNT study 
population. Two SNPs (rs13021737 and rs16951275) were associated with smoking status 
and were therefore excluded, leaving 73 SNPs as instruments for BMI in the current study. 
An externally weighted BMI genetic risk score (GRS) was calculated by multiplying the 
number of BMI-increasing alleles for each variant by the variant’s coefficient for BMI from 
the GIANT study 16, and summing across the 73 variants. The BMI GRS showed an F-
statistic of 1122 and explained 2.0% of the variance in BMI in the HUNT2 Study. 
Forty-nine SNPs were chosen as instruments for sex-combined WHR from adults of 
mainly European ancestry in the GIANT study at a p value <5x10-8 17; sex-specific 
instruments were suggested including 48 SNPs for women and 33 SNPs for men at a p value 
<0.05. In HUNT2, data of 47, 46 and 32 SNPs were available and used to generate weighted 
WHR GRS for total, for women and for men respectively. None of these SNPs were 
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associated with smoking or other potential confounders. The weights in GRS for total, 
women and men were coefficients for WHR from sex-combined or sex-specific analyses in 
the GIANT study 17. The WHR GRS showed an F statistic of 174 and explained 0.3% of the 
variation in WHR in the total HUNT2 cohort. As HUNT was part of the GIANT study, we 
acknowledge that the calculation of weighted BMI and WHR GRS may be minimally biased. 
Asthma and associated genetic variants 
Asthma was defined as ever asthma, doctor diagnosed asthma and doctor diagnosed active 
asthma based on self-report. Ever asthma was defined according to an affirmative answer to 
the question “Do you have or have you had asthma?”. Doctor diagnosed asthma was based on 
participant’s response to the question “Have you been diagnosed as having asthma by a 
doctor?”. Individuals with doctor diagnosed active asthma also confirmed wheezing 
symptoms and/or use of asthma medication in the last 12 months. Having atopic status was 
defined as those who reported having allergic rhinitis in combination with reported use of 
allergy medication or with reported allergic symptoms to pollen or pets. Based on questions 
about 1) daytime symptoms, 2) night awakes, 3) reliever medication use and 4) activity 
limitations 18, levels of asthma symptom control were classified as controlled (0 of the above 
items) vs. partly controlled (1-4 items) in the doctor diagnosed active asthma individuals. The 
classification was adapted from the 2015 Global Initiative for Asthma (GINA) Global 
Strategy for Asthma Management and Prevention 19. 
In the HUNT2 Study, seven asthma-associated SNPs from the GABRIEL study (p <5x10-8 
for asthma risk at all ages), a large GWAS on asthma in people with European ancestry 20, 
were used in a weighted asthma GRS. The weighted asthma GRS explained about 0.4% 
(based on peudo R2) of the variation in liability for ever asthma in the HUNT2 cohort. In a 
two-sample MR, 26 of 34 SNPs derived from a latest GWAS on asthma (p <5x10-8 for adult-
onset asthma) 21 were used as instrumental variables for asthma. Data of the 26 SNPs were 
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not accessible in the HUNT2 Study. Three of the 26 SNPs were in linkage disequilibrium 
(R2 >0.1) with three of the seven SNPs used in the HUNT2 Study. 
Statistical analysis 
First, we evaluated the potential causal BMI-asthma association among 56105 participants 
who had complete information on the BMI SNPs, BMI and asthma. We performed one-
sample MR analyses applying the Wald method 22, with which MR-derived odds ratio (OR) 
and 95% confidence interval (CI) were calculated by the natural exponential function of the 
ratio of coefficient of GRS-outcome (asthma) association over coefficient of GRS-exposure 
(BMI) association. The coefficient of the GRS-asthma association was derived after 
adjustment for family history of asthma and education because there were associations of the 
BMI GRS with the two variables after a correction of multiple testing (Table S1). The 
coefficient of the GRS-BMI association was derived after adjustment for sex, age and age-
squared 16. The MR-derived OR corresponded to an effect of 1 standard deviation (SD) 
increase in genetically determined BMI.  
Second, we evaluated the potential causal WHR-asthma association in 55671 of the 
56105 adults who had complete information on the WHR SNPs, WHR and asthma. A similar 
approach was employed to calculate the MR-derived OR corresponding to 1 SD increase in 
genetically determined WHR. The coefficient of the GRS-asthma association was derived 
without adjustment for other variables as the WHR GRS was not associated with the potential 
confounders. The coefficient of the GRS-WHR association was derived after adjustment for 
sex, age, age-squared, and BMI 17.  
Third, we performed sensitivity analyses to test the robustness of the BMI-asthma 
association using the inverse-variance weighted (IVW) method and the MR-Egger method. 
The IVW method combines ratio estimates derived from each genetic variant in a random-
effect meta-analysis model 23. Additionally, we tested for heterogeneity among the 73 BMI 
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SNPs by presenting the I2 value in the IVW method 24. The MR-Egger method is relatively 
robust to horizontal pleiotropy 25, by which we calculated the intercept and 95% CI of the 
MR-Egger regression line 25. Substantial horizontal pleiotropy is less likely if the intercept 
does not deviate markedly from zero. We also performed two-sample MR analyses to provide 
more evidence on the central adiposity-asthma relationship using the publicly accessible MR 
BASE 26; summary-level statistics were extracted from the GIANT Consortium on WHR/WC 
17 and the GABRIEL study on doctor diagnosed asthma 20. 
At last, we evaluated the possibility of reverse causation between asthma and adiposity 
using both one-sample MR in the HUNT2 Study and two-sample MR with summary statistics 
from the GWAS 16 17 21. In the HUNT2, the effect estimate was calculated as the ratio of 
coefficient of asthma GRS-BMI association over the coefficient of asthma GRS-asthma 
association, and it corresponded to the effect of one unit increase in ln (OR) of genetically 
determined asthma on the BMI values. A similar approach was employed for the causal 
asthma-WHR association. Effect estimates of the two-sample MR were derived using the MR 
BASE 26.  
We also conducted observational analyses between adiposity markers and prevalent 
asthma in the HUNT2 cohort, in which we adjusted for important confounders including age 
(as a continuous variable), family history of asthma (yes and no), active smoking [never, 
former (0–10.0, 10.1–20.0, ≥20.1 pack-years), current (0–10.0, 10.1–20.0, ≥20.1 pack-years), 
and unknown], physical activity (inactive, low, moderate, high, and unknown), education 
(<10, 10–12, ≥13 years, and unknown), and having economic difficulties (yes, no, and 
unknown).  
All statistical analyses were performed in R (version 3.5.1) or STATA/MP 15.1 (College 




The characteristics of the HUNT2 cohort are described in Table 1. The prevalence of ever 
asthma, doctor diagnosed asthma and doctor diagnosed active asthma in the HUNT2 
population was 8.9%, 5.5% and 3.7%, respectively, and it was comparable in women and 
men. The MR estimates demonstrated a larger effect of BMI than the observational estimates, 
i.e. 36%-49% vs. 15%-17% higher ORs for asthma by the three definitions per 1 SD (4.1 
kg/m2) increase in BMI (Table 2). Although the ORs per 1 SD (4.1 kg/m2) in men were 
generally lower than those in women in the MR analyses, statistical tests showed little 
evidence of effect modification by sex (p>0.30 for all). 
The proportion of atopic vs. non-atopic asthma was 36.9% vs. 63.1% for ever asthma, 
47.0% vs. 53.0% for doctor diagnosed asthma and 48.1% vs. 51.9% for doctor diagnosed 
active asthma (Table 3). In the observational analyses, BMI was similarly associated with 
atopic and non-atopic asthma. However, the MR analyses showed larger ORs for non-atopic 
than atopic asthma (42%-72% vs. 18%-26% increased ORs for the three asthma definitions, 
respectively). The proportions of controlled vs. partly controlled doctor diagnosed active 
asthma were 26.9% vs. 72.0% (Table 3). The effect of BMI on controlled asthma was similar 
to that on the partly controlled asthma. Similar patterns for asthma by atopic status or by 
levels of symptom control were observed in women and men despite the reduced statistical 
power by stratification (Tables S2 and S3).  
There were positive associations between WHR and asthma in the total cohort and by sex 
in the observational analysis after additional adjustment for BMI (Table 4). However, the MR 
estimates showed little evidence of an association between genetically determined WHR and 
asthma, and no sex difference was found (p>0.27 for all).  
Results from the IVW method were comparable with those from the Wald method (Table 
S4). The I2 values showed relatively low heterogeneity among the 73 BMI genetic variants. 
12 
 
Results from the MR-Egger method showed consistent evidence for ever asthma and doctor 
diagnosed asthma (Table S4), and the corresponding intercepts did not deviate from zero. 
However, the causal OR for doctor diagnosed active asthma was inconsistent and the 
intercept showed deviation from zero. The two-sample MR analyses showed little evidence 
on a causal association of WHR (Table S5) or WC (Table S6) with doctor diagnosed asthma. 
Regarding the reverse asthma-adiposity relationship, genetically determined asthma was 
not associated with BMI (Table 5) or WHR (Table S7) in the HUNT2 Study. In two-sample 






We observed evidence of an association between genetically determined BMI and asthma in 
an adult population overall and by sex. The causal association appeared stronger for non-
atopic than atopic asthma, but it was similar for controlled and partly controlled asthma. 
Genetically determined WHR (after adjustment for BMI), however, was not associated with 
the asthma risk in this adult population. There was little evidence to support a reverse 
association between genetically determined asthma and the adiposity markers. 
Comparison with previous studies 
Our finding on the BMI-asthma causal association in the overall population was consistent 
with results from the previous MR studies in children and adults 8-11. A most recent two-
sample MR study using publicly available summary data further confirmed this causal 
direction in adults 27. The similar association between genetically determined BMI and 
asthma in women and men in the current study was supported by prospective cohort studies 1 
3. However, it was not supported by the paediatric MR studies in which one reported a 
stronger causal association in girls 8 and the other reported a stronger association in boys 9. 
Regarding a stronger effect of BMI on non-atopic asthma, our finding was supported by the 
paediatric studies 8 9, but not by an adult MR study that seemed to report a stronger effect on 
atopic asthma 10. Misclassification of atopic status was possible in the latter study as it was 
defined by reported allergic rhinitis only 10, whereas our definition was based on report of 
having allergic rhinitis in combination with reported use of allergy medication or with 
reported allergic symptoms.  
We did not observe an association of genetically determined WHR with asthma. This was 
supported by results from the two-sample MR analyses on the WHR/WC-doctor diagnosed 
asthma associations using data from the MR BASE 26. Genetically determined WHR showed 
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an effect on asthma in a paediatric study 9, suggesting that there might be different aetiologies 
for asthma in children as opposed to adults. No reverse association between genetically 
determined asthma and risk of adiposity was observed in the current and previous studies 9 27. 
Overall, our study supported a causal effect of higher BMI on increased risk of asthma in 
particular non-atopic asthma, but there was little evidence to suggest different effects on the 
levels of asthma symptom control. This indicated that increased BMI might play a more 
important role in causing rather than worsening asthma. Several mechanisms have been 
proposed for the obesity-asthma association, including mechanical mechanisms resulted from 
reduced lung volume and airway diameter due to obesity, and inflammatory mechanisms 
resulted from cytokines, chemokines and hormones produced mainly by abdominal 
adipocytes 28. Our study suggested that mechanical restriction to the lung and airways due to 
obesity might be a major underlying mechanism for the association in adults 28. This is 
supported by 1) a previous MR study in adults showing that genetically predicted BMI was 
associated with reduced lung function 10 and 2) we did not detect an effect of the central 
adiposity reflected by WHR.  
Strengths and limitations 
Our MR study has the following strengths. Apart from providing further evidence on a causal 
BMI-asthma association, we investigated the possibility of effect modification by sex in an 
adult population. We are the first to evaluate a potential causal association between WHR and 
asthma in adults. This is also the first attempt to investigate a potential causal effect of 
adiposity on asthma symptom control. In addition, our study is among the few to evaluate if 
reverse causation exists. Our study included a large homogenous population in which 97% 
were ethnic Norwegians 14, which was favourable in terms of minimizing population 
stratification bias 23. We also included the largest number of BMI SNPs (73 vs. 24-32) 
compared with the previous studies 8-11. 
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We studied thoroughly the three assumptions of the 73 SNPs being instrumental variables 
for BMI: 1) the F statistic of the BMI GRS indicated these SNPs being valid instruments 29; 
2) the SNPs or GRS should not be associated with the measured confounders; and 3) there 
should be no horizontal pleiotropic effects of the BMI genetic variants on risk of asthma. To 
satisfy the second assumption, we first excluded two SNPs (rs13021737 and rs16951275) that 
were associated with smoking status, and further adjusted for family history of asthma and 
education when calculating the MR-derived ORs as they were associated with the BMI GRS. 
However, we cannot exclude the possibility that BMI SNPs or the GRS are associated with 
asthma through unknown confounders. Results from the MR-Egger method, which is 
relatively robust for horizontal pleiotropy, showed consistent associations and little evidence 
of pleiotropy with ever asthma and doctor diagnosed asthma. In addition, the heterogeneity of 
the 73 BMI SNPs was relatively small.  
Nevertheless, our study has several limitations. Weak instrument bias and lack of study 
power were possible, particularly in the evaluation of the WHR-asthma relationship. The 
MR-Egger intercept suggested horizontal pleiotropic effect on doctor diagnosed active 
asthma, which might be explained by the effect of BMI genetic variants on wheezing 11 as it 
was part of the definition of doctor diagnosed active asthma. In addition, the MR studies have 
similar weaknesses as observational studies in terms of selection and information bias. We 
only included 56105 subjects (86% of the 65227 participants) who had complete information 
on the BMI genetic variants, BMI and asthma. Besides, the participation rate in the HUNT2 
Survey was moderate (70%). The excluded (n=9124) compared with the included participants 
(n=56105) were relatively older, lower educated, and more physically inactive, but the 
proportion of BMI ≥25 kg/m2 (60.1% vs. 60.0%) and the prevalence of ever asthma (9.4% vs. 
8.9%) were similar. Overall, selection bias might be possible, but it may not largely influence 
the causal association of BMI with asthma. Although it showed consistent results for the 
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three asthma definitions, misclassification of asthma cannot be ruled out due to self-report, 
particularly among the obese individuals 30. It was also possible that individuals with chronic 
obstructive pulmonary disease (COPD) reported having asthma. About 5% of the ever asthma 
adults reported having cough with phlegm for at least 3 months during each of the past two 
years and had FEV1/FVC ratio <0.70. Anthropometric markers were objectively measured. 
While minor measurement errors are assumed for weight and height, we acknowledge larger 
measurement errors for waist and hip circumferences 31. Evaluation of potential effects of 
other adiposity markers such as fat mass may therefore improve our understanding on the 
underlying mechanisms of the BMI-asthma association in adults. At last, although genetic 
assortments happen long before the onset of disease, which indicates a temporal order in an 
MR study, prospective data may provide additional information.  
In conclusion, our study demonstrated evidence on a similar causal association between 
BMI and asthma risk in women and men. The causal association seemed stronger for non-
atopic asthma, but it was similar for levels of asthma symptom control. The latter suggests 
that increased BMI might play a role in causing rather than worsening asthma. However, 
there was little evidence for an association between genetically determined WHR and asthma 
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Table 1. Description of the HUNT2 cohort, 1995–1997 
 Total Women Men 
No. of subjects 56105 29678 26427 
Age (years)* 49.6±16.6 49.5±16.8 49.6±16.3 
Body mass index (kg/m2)* 26.3±4.1 26.2±4.6 26.5±3.5 
Waist-hip ratio*† 0.84±0.08 0.80±0.06 0.90±0.06 
Family history of asthma, % (no/yes) 85.7/14.3 83.6/16.4 88.1/11.9 
Smoking, % (never/ever/unknown) 42.2/55.9/1.9 46.7/51.0/2.3 37.1/61.4/1.5 
Physical activity, % (inactive/active/unknown) 21.3/48.5/30.2 22.9/42.7/34.4 19.6/54.9/25.5 
Education (years), % (<10/≥10/unknown) 34.1/61.3/4.6 37.5/57.4/5.1 30.2/65.7/4.1 
Economic difficulties, % (no/yes/unknown) 49.8/21.6/28.6 50.2/22.9/27.0 49.4/20.2/30.4 
HUNT2: The Nord-Trøndelag Health Study Survey 2 
*Data are given as mean ± standard deviation 





Table 2. Associations between BMI and ever asthma, doctor diagnosed asthma, and doctor diagnosed active asthma in the HUNT2 Study 
 Number of asthma/ no asthma 
Observational estimates MR estimates 
OR* 95% CI OR† 95% CI 
Total (n=56105)      
  Ever asthma 4987/51118 1.17 (1.14 to 1.21) 1.36 (1.10 to 1.68) 
  Doctor diagnosed asthma 3061/53044 1.15 (1.11 to 1.19) 1.49 (1.14 to 1.94) 
  Doctor diagnosed active asthma 2083/54022 1.17 (1.12 to 1.22) 1.40 (1.02 to 1.93) 
Women (n=29678)      
  Ever asthma 2588/27090 1.21 (1.17 to 1.25) 1.47 (1.12 to 1.93) 
  Doctor diagnosed asthma 1624/28054 1.20 (1.15 to 1.25) 1.64 (1.17 to 2.30) 
  Doctor diagnosed active asthma 1134/28544 1.21 (1.15 to 1.28) 1.39 (0.93 to 2.07) 
Men (n=26427)      
  Ever asthma 2399/24028 1.12 (1.06 to 1.17) 1.24 (0.88 to 1.74) 
  Doctor diagnosed asthma 1437/24990 1.07 (1.00 to 1.14) 1.31 (0.85 to 2.03) 
  Doctor diagnosed active asthma 949/25478 1.08 (1.00 to 1.17) 1.43 (0.84 to 2.43) 
BMI: body mass index; CI: confidence interval; HUNT2: The Nord-Trøndelag Health Study Survey 2; MR: Mendelian randomization; OR: odds 
ratio 
*Per standard deviation (4.1 kg/m2) increase in BMI. Model was adjusted for sex, age, family history of asthma, pack-years of active smoking, 
physical activity, education and economic difficulties 
†Per standard deviation (4.1 kg/m2) increase in genetically determined BMI after adjustment for family history of asthma and education. Wald 
method was applied for calculating MR estimates using externally weighted BMI genetic risk score (GRS). The weighted BMI GRS was 
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calculated by multiplying the number of BMI-increasing alleles for each variant by the variant’s coefficient for BMI from the GIANT study 16, 









Observational estimates MR estimates 
Atopic asthma Non-atopic asthma Atopic asthma Non-atopic asthma 
OR* 95% CI OR* 95% CI OR† 95% CI OR† 95% CI 
Ever asthma 1838/3149 1.18 (1.13 to 1.23) 1.17 (1.13 to 1.21) 1.25 (0.89 to 1.77) 1.42 (1.09 to 1.85) 
Doctor diagnosed asthma 1440/1621 1.16 (1.11 to 1.22) 1.15 (1.09 to 1.20) 1.26 (0.86 to 1.85) 1.72 (1.20 to 2.46) 






Observational estimates MR estimates 
Controlled asthma Partly controlled asthma Controlled asthma 
Partly controlled 
asthma 
OR* 95% CI OR* 95% CI OR† 95% CI OR† 95% CI 
Doctor diagnosed active asthma# 561/1500 1.21 (1.11 to 1.30) 1.16 (1.10 to 1.21) 1.43 (0.78 to 2.61) 1.44 (0.99 to 2.10) 
BMI: body mass index; CI: confidence interval; HUNT2: The Nord-Trøndelag Health Study Survey 2; MR: Mendelian randomization; OR: odds 
ratio 
*Per standard deviation increase in BMI. Model was adjusted for sex, age, family history of asthma, pack-years of active smoking, physical 
activity, education and economic difficulties 
†Per standard deviation increase in genetically determined BMI after adjustment for family history of asthma and education. Wald method was 
applied for calculating MR estimates using externally weighted BMI genetic risk score (GRS). The weighted BMI GRS was calculated by 
multiplying the number of BMI-increasing alleles for each variant by the variant’s coefficient for BMI from the GIANT study 16, and summing 
across the 73 variants. 
#22 individuals with doctor diagnosed active asthma were excluded due to missing of the asthma symptom control variables  
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Table 4. Associations between WHR and ever asthma, doctor diagnosed asthma, and doctor diagnosed active asthma in the HUNT2 Study 
 Number of asthma/no asthma 
Observational estimates MR estimates 
OR* 95% CI OR† 95% CI 
Total (n=55671) 
 
     
  Ever asthma 4954/50717 1.24 (1.18 to 1.30) 1.00 (0.61 to 1.63) 
  Doctor diagnosed asthma 3042/52629 1.23 (1.16 to 1.30) 1.01 (0.55 to 1.86) 
  Doctor diagnosed active asthma 2073/53598 1.26 (1.18 to 1.34) 1.17 (0.56 to 2.44) 
Women (n=29291)      
  Ever asthma 2562/26729 1.18 (1.11 to 1.25) 1.11 (0.70 to 1.78) 
  Doctor diagnosed asthma 1607/27684 1.12 (1.04 to 1.21) 0.95 (0.53 to 1.70) 
  Doctor diagnosed active asthma 1125/28166 1.18 (1.08 to 1.29) 1.22 (0.61 to 2.43) 
Men (n=26380)      
  Ever asthma 2392/23988 1.35 (1.26 to 1.45) 0.48 (0.14 to 1.61) 
  Doctor diagnosed asthma 1435/24945 1.42 (1.30 to 1.55) 0.73 (0.16 to 3.37) 
  Doctor diagnosed active asthma 948/25432 1.40 (1.26 to 1.56) 0.61 (0.09 to 3.96) 
CI: confidence interval; HUNT2: The Nord-Trøndelag Health Study Survey 2; MR: Mendelian randomization; OR: odds ratio; WHR: waist-hip 
ratio 
*Per standard deviation increase in WHR. Model was adjusted for sex, age, body mass index, family history of asthma, pack-years of active 
smoking, physical activity, education and economic difficulties 
†Per standard deviation increase in genetically determined WHR. Wald method was applied for calculating MR estimates using externally 
weighted WHR genetic risk score (GRS). The weighted WHR GRS was calculated by multiplying the number of WHR-increasing alleles for 
27 
 









Coefficient* 95% CI 
Ever asthma -0.03 (-0.24 to 0.17) 0.73 
Doctor diagnosed asthma -0.04 (-0.24 to 0.17) 0.73 
Doctor diagnosed active asthma -0.04 (-0.24 to 0.17) 0.73 
BMI: body mass index; CI: confidence interval; HUNT2: The Nord-Trøndelag Health Study Survey 2; MR: Mendelian randomization 
*Per unit increase in ln (OR) of genetically determined asthma. Wald method was applied for MR estimates using externally weighted allele 
score. The externally weighted asthma allele score was calculated by multiplying the number of asthma risk-increasing alleles for each variant 
by the variant’s coefficient for asthma from the GABRIEL study 20, and summing across the 7 variants. 
 
